Altwerger G

No ORCID on file · 4 papers in corpus
case-report 2026
Midgut Volvulus with Necrosis: A Complication of Endometriosis
CRSLS : MIS case reports from SLS ·doi:10.4293/crsls.2025.00122

BACKGROUND: Deeply infiltrating endometriosis (DIE) can involve the bowel leading to necrosis with septic shock, a rare complication occurring in 5% of endometriosis patients. This case report aims to illustrate a life-threatening complicat…

2020
Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.06.484

ObjectiveWhole-exome-sequencing (WES) studies reported c-MYC gene-amplification and HUWE1 gene deletion/mutations in a significant number of cervical-cancer-patients (CC) suggesting HUWE1/c-MYC pathway as potential therapeutic target. We in…

2018
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.03.050

IntroductionSince the majority of patients are diagnosed at an advanced stage, ovarian cancer remains the most lethal gynecologic malignancy. There is no single biomarker with the sensitivity and specificity required for effective cancer sc…

2018
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-18-0864

Purpose: Uterine serous carcinoma (USC) is a rare and aggressive variant of endometrial cancer. Whole-exome sequencing (WES) studies have recently reported c-Myc gene amplification in a large number of USCs, suggesting c-Myc as a potential …